Arecor has presently built over a dozen separate patent families covering the Company’s core proprietary technologies for stabilization of biologicals and applications on specific products. These patent applications, together with the Company’s proprietary know-how, provides Arecor with several options which can be used singly or in combination to confer effective patent protection for individual biologics, or classes of biologics. Patent applications cover Arestat-R™ (protection during exposure to ionizing radiation), as well as, Arestat-T™ (protection against thermal or concentration induced degradation). Since specific degradation pathways may be more or less important in the case of specific proteins, the relative importance of each patent application may vary by protein.

Arecor is working with both UK and US patent advisors to ensure that patent applications clearly disclose the novelty of the core inventions. Arecor’s clients can benefit through patented formulations incorporating Arestat™.

Arecor’s IP strategy is designed to significantly limit the competitors’ ability to develop formulations which can achieve the same objectives through the similar means.